Literature DB >> 23239325

A novel approach to the analysis of SUMOylation with the independent use of trypsin and elastase digestion followed by database searching utilising consecutive residue addition to lysine.

Navin Chicooree1, John R Griffiths, Yvonne Connolly, Chong-Teik Tan, Angeliki Malliri, Claire E Eyers, Duncan L Smith.   

Abstract

RATIONALE: Identification of sites of protein SUMOylation is of great importance due its functional diversity within the cell. To date, most approaches to this problem rely on site-directed mutagenesis and/or highly specialised mass spectrometry approaches. We present a novel alternative approach to the site mapping of SUMOylation using trypsin and elastase digestion, routine mass spectrometry and an unbiased isotag database searching strategy.
METHODS: SUMOylated protein samples were digested with a number of enzymes and the resulting peptides separated using liquid chromatography. Analysis was carried out on both linear ion trap Orbitrap and quadrupole-time-of-flight (Q-TOF)-based mass spectrometers equipped with electrospray ionisation. The data files were subsequently searched using the Mascot algorithm with multiple variable tag modifications corresponding to SUMO-derived fragments. The utility of this approach was demonstrated with di-SUMO 2, di-SUMO 3, SUMO 1-RanGap(418-587) 1 and an enriched population of SUMOylated proteins.
RESULTS: Unbiased database searches led to the identification of a number of analytically useful isotags ranging in length from two to four residues. Isopeptide fragments were generated including QTGG (di-SUMO-2/3), TGG (di-SUMO-2/3) and GG (SUMO-1). The method was validated by successfully mapping a number of sites of SUMO modification on SUMO-modified proteins enriched from a cell lysate.
CONCLUSIONS: This combination of relaxed enzyme specificity, shortened isotag generation and unbiased database searching enabled confident identification of novel analytically useful SUMOylated isopeptides without a requirement for mutagenesis.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23239325     DOI: 10.1002/rcm.6425

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  7 in total

1.  Mass spectral enhanced detection of Ubls using SWATH acquisition: MEDUSA--simultaneous quantification of SUMO and ubiquitin-derived isopeptides.

Authors:  John R Griffiths; Navin Chicooree; Yvonne Connolly; Milla Neffling; Catherine S Lane; Thomas Knapman; Duncan L Smith
Journal:  J Am Soc Mass Spectrom       Date:  2014-02-19       Impact factor: 3.109

Review 2.  SUMO proteomics to decipher the SUMO-modified proteome regulated by various diseases.

Authors:  Wei Yang; Wulf Paschen
Journal:  Proteomics       Date:  2014-10-28       Impact factor: 3.984

Review 3.  Regulation of translesion DNA synthesis: Posttranslational modification of lysine residues in key proteins.

Authors:  Justyna McIntyre; Roger Woodgate
Journal:  DNA Repair (Amst)       Date:  2015-02-18

4.  Preparing to read the ubiquitin code: a middle-out strategy for characterization of all lysine-linked diubiquitins.

Authors:  Amanda E Lee; Carlos A Castañeda; Yan Wang; David Fushman; Catherine Fenselau
Journal:  J Mass Spectrom       Date:  2014-12       Impact factor: 1.982

Review 5.  Proteomics strategies to identify SUMO targets and acceptor sites: a survey of RNA-binding proteins SUMOylation.

Authors:  Giuseppe Filosa; Silvia M L Barabino; Angela Bachi
Journal:  Neuromolecular Med       Date:  2013-08-25       Impact factor: 3.843

6.  A Chemical and Enzymatic Approach to Study Site-Specific Sumoylation.

Authors:  Claudio P Albuquerque; Eyan Yeung; Shawn Ma; Ting Fu; Kevin D Corbett; Huilin Zhou
Journal:  PLoS One       Date:  2015-12-03       Impact factor: 3.240

7.  The S. pombe translation initiation factor eIF4G is Sumoylated and associates with the SUMO protease Ulp2.

Authors:  Jirapas Jongjitwimol; Min Feng; Lihong Zhou; Oliver Wilkinson; Lauren Small; Robert Baldock; Deborah L Taylor; Duncan Smith; Lucas D Bowler; Simon J Morley; Felicity Z Watts
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.